Diana E. Cunningham
Papers
1
Total Citations
54
H-Index
1
About
Diana E. Cunningham is a leading clinical researcher in head and neck oncology, with a focused expertise in the intersection of human papillomavirus (HPV) biology and patient-reported outcomes. Her seminal work, "Quality of life in head and neck cancer patients: Impact of HPV and primary treatment modality" (2013), has garnered 54 citations and fundamentally shaped how clinicians evaluate posttreatment survivorship. In this landmark retrospective study of 177 patients, Cunningham was among the first to stratify quality-of-life (QOL) outcomes by both HPV/p16 status and primary treatment modality, demonstrating that HPV-positive patients often report distinct functional and psychosocial trajectories compared to their HPV-negative counterparts. This contribution has been instrumental in moving the field beyond survival metrics alone, establishing QOL as a critical endpoint in treatment decision-making. Her research has directly informed clinical guidelines for de-escalation protocols in HPV-driven cancers, helping to reduce long-term toxicity while preserving oncologic outcomes. Cunningham’s work continues to influence head and neck cancer care, bridging virology, treatment selection, and the lived experience of patients.
Research Focus
Key Achievements
Top Papers
- 1